Performance Characteristics of the BluePrint® Breast Cancer Diagnostic Test.

Mittempergher, Lorenza; Delahaye, Leonie Jmj; Witteveen, Anke T; Snel, Mireille Hj; Mee, Sammy; Chan, Bob Y; Dreezen, Christa; Besseling, Naomi; Luiten, Ernest Jt

Mittempergher, Lorenza; Delahaye, Leonie Jmj; Witteveen, Anke T; Snel, Mireille Hj; Mee, Sammy; Chan, Bob Y; Dreezen, Christa; Besseling, Naomi; Luiten, Ernest Jt.

Afiliação

Mittempergher L; Research and Development, Agendia N.V., Science Park 406, 1098 XH Amsterdam, The Netherlands.
Delahaye LJ; Research and Development, Agendia N.V., Science Park 406, 1098 XH Amsterdam, The Netherlands.
Witteveen AT; Research and Development, Agendia N.V., Science Park 406, 1098 XH Amsterdam, The Netherlands.
Snel MH; Research and Development, Agendia N.V., Science Park 406, 1098 XH Amsterdam, The Netherlands.
Mee S; Product Support, Agendia Inc., 22 Morgan, Irvine, CA 92780, USA.
Chan BY; Product Support, Agendia Inc., 22 Morgan, Irvine, CA 92780, USA.
Dreezen C; Research and Development, Agendia N.V., Science Park 406, 1098 XH Amsterdam, The Netherlands.
Besseling N; Research and Development, Agendia N.V., Science Park 406, 1098 XH Amsterdam, The Netherlands.
Luiten EJ; Department of Surgery, Amphia Hospital, Molengracht 21, 4818 CK, Breda, The Netherlands.

Transl Oncol ; 13(4): 100756, 2020 Apr.

Article em En | MEDLINE | ID: mdl-32208353

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Prognostic_studies Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google